Synthesis and evaluation of non-dimeric HCV NS5A inhibitors.

Bioorg Med Chem Lett

Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, and Veterans Affairs Medical Center, Decatur, GA 30033, USA.

Published: April 2013

Based on the symmetrical bidentate structure of the NS5A inhibitor BMS-790052, a series of new monodentate molecules were designed. The synthesis of 36 new non-dimeric NS5A inhibitors is reported along with their ability to block HCV replication in an HCV 1b replicon system. Among them compound 5a showed picomolar range activity along with an excellent selectivity index (SI > 90,000).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602317PMC
http://dx.doi.org/10.1016/j.bmcl.2013.02.023DOI Listing

Publication Analysis

Top Keywords

ns5a inhibitors
8
synthesis evaluation
4
evaluation non-dimeric
4
non-dimeric hcv
4
hcv ns5a
4
inhibitors based
4
based symmetrical
4
symmetrical bidentate
4
bidentate structure
4
structure ns5a
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!